FebriDx for C-reactive protein and myxovirus resistance protein A testing

  • Medtech innovation briefing
  • MIB224
  • Published: 
Download (PDF)

Overview

NICE has developed a medtech innovation briefing (MIB) on FebriDx for C-reactive protein and myxovirus resistance protein A testing.

What are MIBs?

This advice updates and replaces medtech innovation briefing 114.